Observational studyRheumatology (Oxford, England)2018

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Lucía Silva-Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.